Umbilical cord blood mononuclear cells

BIOLOGICAL4 trials

Sponsors

Hebei Medical University, Shandong Qilu Stem Cells Engineering Co., Ltd., Qianfoshan Hospital, Beijing GoBroad Hospital

Conditions

Bone NonunionLiver CirrhosisRefractory Immune Effector Cell-related HemocytopeniaUlcerative Colitis

Phase 1

Umbilical Cord Blood Mononuclear Cells Therapy in Liver Cirrhosis

Hebei Medical UniversityLiver Cirrhosis

Start: 2012-01-31End: 2014-12-31Target: 10Updated: 2013-11-15

Unknown Phase

Clinical Study of Cord Blood Mononuclear Cells on Treatment of Hormone-resistant or Hormone-dependent Ulcerative Colitis

Shandong Qilu Stem Cells Engineering Co., Ltd.Ulcerative Colitis

Start: 2021-06-01End: 2022-12-31Target: 50Updated: 2021-05-12

Clinical Study of Umbilical Cord Blood Mononuclear Cells (UCB-MNCs) in the Treatment of Traumatic Fracture Healing

Qianfoshan HospitalBone Nonunion

Start: 2020-12-10End: 2022-12-10Target: 40Updated: 2021-08-09

A Randomized Controlled, Open, Single-center Clinical Study Evaluating the Efficacy and Safety of Umbilical Cord Blood Mononuclear Cells in Patients with Refractory Immune Effector Cell-related Hemocytopenia

Not yet recruitingNCT06729320

Beijing GoBroad HospitalRefractory Immune Effector Cell-related Hemocytopenia

Start: 2024-12-01End: 2025-12-01Target: 40Updated: 2024-12-11